Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (U19 AI117905)
Human Vaccines Project Initiative, Inc.
Received: 1 February 2019
Accepted: 18 November 2019
First Online: 4 December 2019
Ethics approval and consent to participate
: The studies were approved by the Institutional Review Board of Vanderbilt University Medical Center; adult healthy subject samples were obtained after written informed consent was obtained by the Vanderbilt Clinical Trials Center. Cord blood cells were procured by the National Disease Research Interchange (NDRI), with support from NIH grant U42 OD11158. The HIV/Flu subject samples were obtained after written informed consent was obtained by the NIH-funded Tennessee Center for AIDS Research, with support from NIH grant P30 AI110527.
: Not applicable.
: J.E.C. has served as a consultant for Takeda Vaccines, Sanofi Pasteur, Pfizer, and Novavax, is on the Scientific Advisory Boards of CompuVax, GigaGen, and Meissa Vaccines and is Founder of IDBiologics, Inc. All other authors declare they have no competing interests.